Company Profiles

driven by the PitchBook Platform

Anida Pharma

Description

Developer of therapy to treat Parkinson's disease. The company develops new therapies for orphan neurological indications with its current development pipeline focusing on amyotrophic lateral sclerosis.

2013

Founded

PRIVATE

Status

Angel

Latest Deal Type

1

Investors

Description

Developer of therapy to treat Parkinson's disease. The company develops new therapies for orphan neurological indications with its current development pipeline focusing on amyotrophic lateral sclerosis.

Website:

www.anidapharma.com

Ownership Status

Privately held (backing)

Financing Status

Angel-Backed

Primary Industry

Drug Discovery

Other Industries

Pharmaceuticals

Primary Office

155 Brookline Street Suite 005 Cambridge, MA 02139United States +1 (617) 331-5033
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Anida Pharma's full profile, request a free trial.

Anida Pharma Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Anida Pharma Investors (1)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Michael J. Fox FoundationOther000 0000000 0000
Michael J. Fox Foundation Other

Anida Pharma Executive Team (1)

NameTitleBoard
Seat
Contact
Info
Per Gjorstrup MDFounder, President & Chief Executive Officer
Per Gjorstrup MD Founder, President & Chief Executive Officer
Request full access to PitchBook